Chapters
Introduction
Introduction
0:00
Introduction
0:00
Agenda
Agenda
1:08
Agenda
1:08
Basic immunological principles
Basic immunological principles
4:40
Vaccines
Vaccines
10:40
Vaccines
10:40
Challenges and advantages
Challenges and advantages
19:22
Game changer
Game changer
26:21
Game changer
26:21
COVID19 pandemic
COVID19 pandemic
27:01
COVID19 pandemic
27:01
Production of antigens
Production of antigens
28:27
Production of antigens
28:27
Large amounts of antigens
Large amounts of antigens
29:36
Flexibility
Flexibility
31:20
Flexibility
31:20
Regulatory innovation
Regulatory innovation
34:22
Regulatory innovation
34:22
In principle
In principle
35:34
In principle
35:34
Question time
Question time
36:49
Question time
36:49
Adjuvants
Adjuvants
37:55
Adjuvants
37:55
Injectable or pill
Injectable or pill
40:11
Injectable or pill
40:11
Do the science
Do the science
41:12
Do the science
41:12
C1 vaccine production
C1 vaccine production
44:15
C1 vaccine production
44:15
Limitations of current vaccines
Limitations of current vaccines
46:21
Spike protein conserved among variants
Spike protein conserved among variants
48:21
Can C1 platform be used for manufacturing antibodies
Can C1 platform be used for manufacturing antibodies
52:49
Multivalent vaccine
Multivalent vaccine
54:23
Multivalent vaccine
54:23
Delay in testing
Delay in testing
57:44
Delay in testing
57:44
Sync to video time
Description
5Likes
436Views
2021May 4
Transcript
Follow along using the transcript.
Show transcript
Transcript
NaN / NaN